课题基金 / 基金详情

项目摘要

项目成果

GIL ALTEROVITZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tobacco use, primarily cigarette smoking, is the greatest source of preventable mortality in the world and costs over $160 million in health-related economic losses in the U.S. alone. Nicotine dependence is the primary reason that smokers continue smoking and that most unassisted quit attempts fail within a single week. It is known that nicotine dependence has a genetic component, but that it is a complex trait, i.e., no single gene is responsible for nicotine dependence. Thus, researchers and funding agencies have devoted considerable effort and support to identifying the genetic underpinnings of the trait through whole genome scans, putting us in a unique position to identify global genetic predictors of nicotine dependence. This study proposes to realize the promise of the NIDA-funded Collaborative Genetic Study of Nicotine Dependence (COGEND) whole genome data through the accomplishment of two specific aims: (1) to identify the set of genetic variations underlying the complex trait of nicotine dependence using a cutting-edge computational method called Bayesian networks and (2) to validate the prognostic model in an entirely independent population. This proposal represents the very first step of a broader research program aimed at discovering the complex network of interactions underpinning nicotine dependence. The ultimate result of this program will provide a clinical tool, which will accurately assess the risk of dependency, allow for individualized preventive measures, elucidate the molecular processes of dependence and nominate novel targets for the pharmaceutical treatment of nicotine addiction. Nicotine dependence places an enormous burden on individuals and society. Genetic factors are responsible for at least some part of the condition, and the NIDA has already funded a study, called COGEND, that examined over 40,000 genetic variations in people who were nicotine dependent and who were not nicotine dependent. We propose to use cutting-edge techniques to analyze this large dataset to identify a valid predictive model of nicotine dependence that will help us predict, diagnose, and treat this condition.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12918-017-0403-7
发表时间: 2017-03-14
期刊: BMC systems biology
影响因子: --
作者: [Zollanvari A, Alterovitz G]
通讯作者: Alterovitz G
Automated synthesis and visualization of a chemotherapy treatment regimen network.
化疗治疗方案网络的自动合成和可视化。
DOI: --
发表时间: 2013
期刊: Studies in health technology and informatics
影响因子: --
作者: [Warner,Jeremy, Yang,Peter, Alterovitz,Gil]
通讯作者: Alterovitz,Gil
A bayesian translational framework for knowledge propagation, discovery, and integration under specific contexts.
用于特定背景下知识传播、发现和集成的贝叶斯翻译框架。
DOI: --
发表时间: 2012
期刊: AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science
影响因子: --
作者: [Deng,Michelle, Zollanvari,Amin, Alterovitz,Gil]
通讯作者: Alterovitz,Gil
Is the reduction of dimensionality to a small number of features always necessary in constructing predictive models for analysis of complex diseases or behaviours?
在构建用于分析复杂疾病或行为的预测模型时,是否始终需要将维度降低到少量特征?
DOI: 10.1109/iembs.2011.6090596
发表时间: 2011
期刊: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
影响因子: --
作者: [Zollanvari,Amin, Saccone,NancyL, Bierut,LauraJ, Ramoni,MarcoF, Alterovitz,Gil]
通讯作者: Alterovitz,Gil
6
    Towards a generalizable drug discovery framework based on intrinsically disordered regions
    • 批准号:
      10116778
    • 项目类别:
    • 资助金额:
      $36.99万
    • 财政年份:
      2016
    • 负责人:
      GIL ALTEROVITZ
    • 依托单位:
    NOT-GM-21-028:Towards a generalizable drug discovery framework based on intrinsically disordered regions
    • 批准号:
      10393070
    • 项目类别:
    • 资助金额:
      $1.43万
    • 财政年份:
      2016
    • 负责人:
      GIL ALTEROVITZ
    • 依托单位:
    Automated Integration of Biomedical Knowledge
    • 批准号:
      7945368
    • 项目类别:
    • 资助金额:
      $42.81万
    • 财政年份:
      2009
    • 负责人:
      GIL ALTEROVITZ
    • 依托单位:
    A Holistic Approach to Information Processing for Biomedical Networks
    • 批准号:
      8324015
    • 项目类别:
    • 资助金额:
      $23.89万
    • 财政年份:
      2008
    • 负责人:
      GIL ALTEROVITZ
    • 依托单位:
    国内基金
    海外基金
    Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data